Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk
Year: 2024
Type: article
Source: JACC Heart Failure
Authors: Andrew P. Ambrosy, Alex J. Chang, Beth Davison, Adriaan Voors, Alain Cohen-Solal, Albertino Damasceno, Antoine Kimmoun, Carolyn S.P. Lam, Lars H. Lund, Christopher Edwards, Daniela Tomasoni, Etienne Gayat, Gerasimos Filippatos, Hadiza Saidu, Jan Biegus, Jelena Celutkiene, Jozine M. Ter Maaten, Kamilė Čerlinskaitė-Bajorė, Karen Sliwa, Koji Takagi, Marco Metra, Maria Novosadova, Marianela Barros, Marianna Adamo, Matteo Pagnesi, Mattia Arrigo, Ovidiu Chioncel, Rafael Diaz, Peter S. Pang, Piotr Ponikowski, Gad Cotter, Alexandre Mebazaa
Institutions: Kaiser Permanente, Kaiser Permanente San Francisco Medical Center, Kaiser Permanente Northern California, Inserm, Université Paris Cité, Momentum Research, Marqueurs cardiovasculaires en situation de stress, University Medical Center Groningen, University of Groningen, Hôpital Lariboisière, Eduardo Mondlane University, Centre Hospitalier Régional et Universitaire de Nancy, Défaillance Cardiovasculaire Aiguë et Chronique, Université de Lorraine, National University of Singapore, National University Heart Centre Singapore, National Heart Centre Singapore, Karolinska University Hospital, Karolinska Institutet, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia, Hôpital Saint-Louis, National and Kapodistrian University of Athens, Bayero University Kano, Wroclaw Medical University, Vilnius University, University of Cape Town, Groote Schuur Hospital, Stadtspital Zürich, Carol Davila University of Medicine and Pharmacy, Estudios Clínicos Latinoamérica, Instituto Cardiovascular de Rosario, Indiana University Indianapolis, Indiana University School of Medicine
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4396846093